Healthcare - Press Releases

Date	Title	Company
12-Aug-2021	Covid-19 antibody tests should be used to determine who needs booster jabs, says London Medical Laboratory	London Medical Laboratory
12-Aug-2021	GLOBAL PPE LEADER AT THE FOREFRIONT OF ADHERENCE TO POST – BREXIT MEDICAL DEVICE REGISTRATION	ASAP UK
12-Aug-2021	Cambridge-based Startup CodiKoat Develops World’s Fastest COVID-19-Killing Antiviral Surface Protection	CodiKoat Ltd
11-Aug-2021	PONVORY®▼ (ponesimod), a Once Daily, Oral Therapy Authorised in Great Britain for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis (RMS) with Active Disease Defined by Clinical or Imaging Features	Janssen
11-Aug-2021	CPhI partners with SGS for Company Verification Service	CPhI
11-Aug-2021	NHS chief urges students to join health service as thousands collect results	NHS England
11-Aug-2021	Children’s flu vaccinations in 9 boroughs of London benefit from online system to encourage greater uptake of immunisations	RIVIAM Digital Care
11-Aug-2021	The Russian Direct Investment Fund: on the first anniversary of Sputnik V registration official data from leading countries confirms the vaccine’s high safety and efficacy profile	Russian Direct Investment Fund
11-Aug-2021	AI technology at Barts Health spares at-risk diabetic patients from limb amputation	Clinithink
11-Aug-2021	Spectral MD hosts event to launch a multi-center clinical study for burn wounds	Spectral MD Holdings, Ltd
10-Aug-2021	Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine	Moderna
10-Aug-2021	The Scottish Medicines Consortium recommends Merck & Pfizer’s Bavencio® (avelumab) as Monotherapy for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma (Bladder Cancer)	Merck
10-Aug-2021	Life Science Analytics Market Top Growing Segments and Future Trends	MarketsandMarkets
09-Aug-2021	Messenger apps and patient confidentiality – what every healthcare professional should know	Siilo
09-Aug-2021	SCOTTISH MEDICINES CONSORTIUM (SMC) ACCEPTS TREMFYA®▼ (GUSELKUMAB), THE FIRST IL-23 p19 INHIBITOR TREATMENT, FOR ACTIVE PSORIATIC ARTHRITIS (PsA)	Janssen
06-Aug-2021	BD and CerTest Biotec Announce CE Mark for Molecular Test to Detect, Identify Certain SARS-CoV-2 Variants	BD and CerTest Biotec
06-Aug-2021	The Most Widely Growth Strategies Adopted by Major Players Which are Advancing the Growth of Radiotherapy Market.	MarketsandMarkets
05-Aug-2021	10 key reasons to join SMi's 2nd Annual Next Generation Pharmaceutical Cleanroom Conference	SMi Group
05-Aug-2021	Makara expands women’s health portfolio with new client wins	Makara Health
05-Aug-2021	Latest ONS Covid-19 antibody data is good news, but almost half a million adults will be left unprotected by jabs, warns London Medical Laboratory	London Medical Laboratory